Your browser doesn't support javascript.
loading
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
Chen, Justin A; Huynh, Jasmine C; Wu, Chun-Yi; Yu, Ai-Ming; Matsukuma, Karen; Semrad, Thomas J; Gandara, David R; Li, Tianhong; Riess, Jonathan W; Tam, Kit; Mack, Philip C; Martinez, Anthony; Mahaffey, Nichole; Kelly, Karen L; Kim, Edward J.
Afiliação
  • Chen JA; Division of Hematology and Oncology, Davis Comprehensive Cancer Center, University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.
  • Huynh JC; Division of Hematology and Oncology, Davis Comprehensive Cancer Center, University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.
  • Wu CY; Bioanalysis and Pharmacokinetics Core Facility, University of California, Sacramento, CA, 95817, USA.
  • Yu AM; Department of Biochemistry and Molecular Medicine, University of California, Sacramento, CA, 95817, USA.
  • Matsukuma K; Department of Pathology and Laboratory Medicine, University of California, Sacramento, CA, 95817, USA.
  • Semrad TJ; Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA, 96161, USA.
  • Gandara DR; Division of Hematology and Oncology, Davis Comprehensive Cancer Center, University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.
  • Li T; Division of Hematology and Oncology, Davis Comprehensive Cancer Center, University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.
  • Riess JW; Division of Hematology and Oncology, Davis Comprehensive Cancer Center, University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.
  • Tam K; Division of Hematology and Oncology, Davis Comprehensive Cancer Center, University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.
  • Mack PC; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Martinez A; Office of Clinical Research, Davis Comprehensive Cancer Center, University of California, Sacramento, CA, 95817, USA.
  • Mahaffey N; Office of Clinical Research, Davis Comprehensive Cancer Center, University of California, Sacramento, CA, 95817, USA.
  • Kelly KL; Division of Hematology and Oncology, Davis Comprehensive Cancer Center, University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.
  • Kim EJ; Division of Hematology and Oncology, Davis Comprehensive Cancer Center, University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA. jhkim@ucdavis.edu.
Cancer Chemother Pharmacol ; 90(3): 217-228, 2022 09.
Article em En | MEDLINE | ID: mdl-35907014
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Neoplasias Limite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Neoplasias Limite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha